Vejle

• Study of lunsekimig (SAR443765) compared with placebo in adults with high-risk asthma Recruiting
  2024-513959-33-00 4 2025-05-13 Asthma
• Comparing the Efficacy and Safety of Aspirin Alone versus Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction ( … Recruiting
  2024-517229-18-00 11 2025-04-30 Non-ST-Elevation Myocardial Infarction (NSTEMI)
• A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-experienced Participants with Active Psoriatic Arthritis Recruiting
  2024-517284-23-00 5 2025-04-23 Active Psoriatic Arthritis
• A trial to learn how well surovatamig (AZD0486) works and how safe it is in adults with certain blood cancers Recruiting
  2023-505789-27-00 4 2025-04-14 Relapsed or Refractory Non-Hodgkin Lymphoma
• FDG-PET/CT versus conventional CT for response monitoring in metastatic breast cancer: a multicenter randomized clinical trial (MONITOR-RCT) Recruiting
  2023-508591-11-00 5 2025-02-25 Metastatic breast cancer
• A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext … Recruiting
  2022-502877-41-01 9 2025-02-10 Pulmonary sarcoidosis with or without extrapulmonary manifestations
• C2321003: A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men with Metastatic Castration-Resistant … Recruiting
  2024-511652-40-00 5 2025-02-05 METASTATIC CASTRATION RESISTANT PROSTATE CANCER
• BONG: Reducing severe Breathlessness with Dronabinol in the severe and very severe chronic obstructive pulmonary disease patient group Recruiting
  2024-513593-22-00 10 2025-01-31 Chronic obstructive pulmonary disease
• Brachial plexus nerve block for closed reduction of distal radius fracture Recruiting
  2024-512191-35-00 6 2024-12-10 Distal radius fracture in need of acute closed reduction
• An open-label study to assess reduction of daily asthma medication with tezepelumab in patients 12 to 80 years of age with severe asthma Recruiting
  2024-512113-41-00 5 2024-11-20 Severe Asthma
• The Effect of Topical Tranexamic Acid on Postoperative Complications in Soft Tissue Plastic Surgery. A Multicenter Randomized Controlled Tri … Recruiting
  2023-510381-28-01 6 2024-09-18 Patients undergoing plastic surgical procedures with wounds that would
• Self-administration of subcutaneous Elranatamab in the patients’ homes (ERICA) Recruiting
  2023-507876-30-00 4 2024-09-04 Multiple Myeloma
• HEMODIALYSIS AND ANTIBIOTIC PROPHYLAXIS Recruiting
  2024-515001-26-00 6 2024-07-25 Blood poisoning in patients with renal failure treated with hemodialys
• Clinical trial of MK-2870 in combination with pembrolizumab in people who have had surgery to treat triple negative breast cancer Recruiting
  2023-504962-52-00 5 2024-07-10 Triple negative breast cancer.
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered-Dose Inhaler on Cardiopulmonary Outcomes in C … Recruiting
  2023-507407-59-00 5 2024-07-04 Chronic Obstructive Pulmonary Disease (COPD)
• Safety and diagnostic performance of uPAR PET imaging in localised, untreated prostate cancer. Recruiting
  2023-507111-35-00 9 2024-06-03 Prostate Cancer
• A clinical trial comparing a new treatment (MK-5684) to approved medication for advanced prostate cancer after prior hormonal therapy and ch … Recruiting
  2023-504899-25-00 5 2024-04-04 Metastatic castration resistant prostate cancer
• A study to evaluate the effects and safety of INCA033989 in participants with myelofibrosis or essential thrombocythemia Recruiting
  2022-502514-86-00 1 2024-02-07 Myeloproliferative Neoplasms
• A Phase 1, Open-Label, Multicenter Study of INCA033890 in Participants with Advanced or Metastatic Solid Tumors Recruiting
  2022-502456-31-00 1 2023-11-30 Advanced or metastatic solid tumors
• A randomized phase II study of gemcitabine versus reduced-dose combination chemotherapy in fragile patients with non-resectable pancreatic c … Recruiting
  2024-514291-41-00 4 2023-10-20 Pancreatic cancer
• Does peri-operative treatment with Tranexamic Acid reduce the early relapse rate for patients with melanoma; a randomised controlled trial Recruiting
  2022-502633-26-00 5 2023-08-25 Melanoma Surgery
• Immunotherapy in patients with early dMMR rectal cancer. A Danish DCCG phase II trial Recruiting
  2022-500646-14-00 4 2023-01-31 cancer
• MagnetisMM-6: A Phase 3 Study of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dex … Recruiting
  2024-514139-50-00 5 2022-11-14 Multiple myeloma
• A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination … Recruiting
  2023-503442-30-00 5 2022-10-14 Multiple Myeloma

Showing 49–72 of 179 trials